BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34675167)

  • 1. Comparison of Magnetic Resonance Imaging of the Lower Uterine Segment in Pregnant Women with Central Placenta Previa with and without Placenta Accreta Spectrum from a Single Center.
    Hou S; Song Y; Wu J; Zhou L; Kang S; Chen X; Zhang L; Lu Y; Yue Y
    Med Sci Monit; 2021 Oct; 27():e932759. PubMed ID: 34675167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome.
    Delli Pizzi A; Tavoletta A; Narciso R; Mastrodicasa D; Trebeschi S; Celentano C; Mastracchio J; Cianci R; Seccia B; Marrone L; Liberati M; Cotroneo AR; Caulo M; Basilico R
    Abdom Radiol (NY); 2019 May; 44(5):1873-1882. PubMed ID: 30600374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of MRI-based scoring models for predicting placental invasiveness in high-risk women for placenta accreta spectrum.
    Liu Q; Zhou W; Yan Z; Li D; Lou T; Yuan Y; Rong P; Feng Z
    Eur Radiol; 2024 Feb; 34(2):957-969. PubMed ID: 37589907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can introvoxel incoherent motion MRI be used to differentiate patients with placenta accreta spectrum disorders?
    Lu T; Pu H; Li KD; Mei J; Huang MW; Wang SY
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):531. PubMed ID: 31888572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 8. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraplacental Fetal Vessel Diameter May Help Predict for Placental Invasiveness in Pregnant Women at High Risk for Placenta Accreta Spectrum Disorders.
    Bourgioti C; Konstantinidou AE; Zafeiropoulou K; Antoniou A; Fotopoulos S; Theodora M; Daskalakis G; Nikolaidou ME; Tzavara C; Letsika A; Martzoukos EA; Moulopoulos LA
    Radiology; 2021 Feb; 298(2):403-412. PubMed ID: 33231529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning analysis of MRI-derived texture features to predict placenta accreta spectrum in patients with placenta previa.
    Romeo V; Ricciardi C; Cuocolo R; Stanzione A; Verde F; Sarno L; Improta G; Mainenti PP; D'Armiento M; Brunetti A; Maurea S
    Magn Reson Imaging; 2019 Dec; 64():71-76. PubMed ID: 31102613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
    Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
    J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
    Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
    Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive placenta previa: Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI - useful features for differentiating placenta percreta from placenta accreta.
    Chen X; Shan R; Zhao L; Song Q; Zuo C; Zhang X; Wang S; Shi H; Gao F; Qian T; Wang G; Limperopoulos C
    Eur Radiol; 2018 Feb; 28(2):708-717. PubMed ID: 28770405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 15. The maximum length of T2-dark intraplacental bands may help predict intraoperative haemorrhage in pregnant women with placenta accreta spectrum (PAS).
    Wu X; Zhou R; Lin M; Li Y; Ying W; Li L; Ji W; Zheng K
    Abdom Radiol (NY); 2022 Oct; 47(10):3594-3603. PubMed ID: 35896684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental volume as a novel sign for identifying placenta accreta spectrum in pregnancies with complete placenta previa.
    Yue Y; Wang X; Zhu L; Liu C; Chen D; Lu Y; Liang B
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):52. PubMed ID: 38200440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder involvement in placenta accreta spectrum disorder with placenta previa: MRI findings and outcomes correlation.
    Jariyawattanarat W; Thiravit S; Suvannarerg V; Srisajjakul S; Sutchritpongsa P
    Eur J Radiol; 2023 Mar; 160():110695. PubMed ID: 36657210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal diagnosis of placenta accreta spectrum (PAS) disorders.
    Yu FNY; Leung KY
    Best Pract Res Clin Obstet Gynaecol; 2021 Apr; 72():13-24. PubMed ID: 32747328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percreta score to differentiate between placenta accreta and placenta percreta with ultrasound and MR imaging.
    Pain FA; Dohan A; Grange G; Marcellin L; Uzan-Augui J; Goffinet F; Soyer P; Tsatsaris V
    Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1135-1145. PubMed ID: 35822244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of MRI findings for predicting patient outcomes of placenta accreta spectrum and placenta previa after prophylactic balloon occlusion of the internal iliac artery.
    Tokue H; Tokue A; Tsushima Y
    Eur J Obstet Gynecol Reprod Biol; 2023 Mar; 282():31-37. PubMed ID: 36630816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.